|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||87.87 - 88.88|
|52 Week Range||62.50 - 92.97|
|PE Ratio (TTM)||12.18|
|Dividend & Yield||3.30 (3.47%)|
|1y Target Est||N/A|
Forecasts for global sales of pharmaceuticals have declined for the first time in a decade as continuing pressure on prices in the key U.S. market has caused analysts to moderate revenue expectations, according to a report on Tuesday. Evaluate Pharma, which compiles consensus numbers based on analysts' forecasts, said worldwide drug sales were now expected to hit $1.06 trillion in 2022, down from $1.12 trillion predicted a year ago for the same period. It is the first time in 10 years that total drug sales have failed to beat the previous year's forecast level.
Global sales projections for the pharmaceuticals industry have been cut by a closely watched forecaster amid signs rampant drug price inflation in the US is starting to ease after years of public pressure. ...
The Zacks-categorized Large Cap Pharmaceuticals industry is among the top 21% of the 256 Zacks-ranked industries -- here is a look at 4 top-ranked stocks from this sector.